# PREDIGA 2: Spanish Acronym of "Educational and Diagnostic Project for Gaucher and ASMD"

> **NCT05641103** · — · COMPLETED · sponsor: **Fundación Española de Hematología y Hemoterapía** · enrollment: 122 (actual)

## Conditions studied

- Gaucher Disease
- Acid SphingoMyelinase Deficiency
- ASMD
- Niemann-Pick Diseases
- Splenomegaly

## Interventions

- **OTHER:** Patient with splenomegaly or splenectomy

## Key facts

- **NCT ID:** NCT05641103
- **Lead sponsor:** Fundación Española de Hematología y Hemoterapía
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-21
- **Primary completion:** 2024-09-30
- **Final completion:** 2024-10-31
- **Target enrollment:** 122 (ACTUAL)
- **Last updated:** 2026-02-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05641103

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05641103, "PREDIGA 2: Spanish Acronym of "Educational and Diagnostic Project for Gaucher and ASMD"". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05641103. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*